Reply to J. Warner-Cohen et al

Affiliations

Comment

Erin M Bange et al. JCO Oncol Pract. 2020 Dec.

. 2020 Dec;16(12):845.

doi: 10.1200/OP.20.00603. Epub 2020 Sep 17.

¹ Erin M. Bange, MD; Kim A. Reiss, MD; and Ronac Mamtani, MD, MSCE, Hospital of the University of Pennsylvania, Philadelphia, PA.

No abstract available

Comment on

Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.
Bange EM, Doucette A, Gabriel PE, Porterfield F, Harrigan JJ, Wang R, Wojcieszynski AP, Boursi B, Mooney BI, Reiss KA, Mamtani R. Bange EM, et al. JCO Oncol Pract. 2020 Aug;16(8):e678-e687. doi: 10.1200/JOP.19.00328. Epub 2020 Mar 4. JCO Oncol Pract. 2020. PMID: 32130074 Free PMC article.
Delicate Balance Between Quality and Quantity of Life: Palliative Chemotherapy for Metastatic Pancreatic Adenocarcinoma.
Warner-Cohen J, Saif MW. Warner-Cohen J, et al. JCO Oncol Pract. 2020 Dec;16(12):845. doi: 10.1200/OP.20.00340. Epub 2020 Aug 11. JCO Oncol Pract. 2020. PMID: 32780639 No abstract available.